Myriad Genetics reported 12M in Pre-Tax Profit for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Accelerate Diagnostics AXDX:US -21674000 2.56M
Becton, Dickinson and BDX:US $ 1023M 108M
Biocept BIOC:US $ -1.83M 4.43M
Danaher DHR:US $ 2304M 109M
Exact Sciences EXAS:US $ -172.89M 101.08M
Fluidigm FLDM:US $ -17.66M 2.83M
Genmark Diagnostics GNMK:US $ -3.7M 0.46M
Johnson & Johnson JNJ:US $ 7776M 515M
Luminex LMNX:US $ 11.04M 5.81M
Myriad Genetics MYGN:US 12M 18.2M
Nanostring Technologies NSTG:US $ -26.94M 0.71M
Orasure Technologies OSUR:US $ 2.25M 8.06M
Oxford Immunotec Global OXFD:US $ 0.06M 9.9M
Pacific Biosciences Of California PACB:US $ -41M 46.43M
Quest Diagnostics DGX:US $ 554M 120M
Thermo Fisher Scientific TMO:US $ 2573M 838M
Veracyte VCYT:US $ 9.19M 19.75M
Waters WAT:US $ 189.75M 22.97M